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The modern era of transplantation began in the early 1900s
when surgeons Aléxis Carrel and Charles C. Guthrie devel-
oped the blood vessel suture technique and performed
experimental transplants. The first successful procedure was
a kidney transplant performed in 1954 involving two twin
siblings in Boston.
Transplantations in Brazil began in 1964, also starting with
kidney transplants, followed by heart, liver, intestine and
pancreas transplants, all of which first occurred in 1968.
However, the results were discouraging, and the solid organ
transplantation program, except for kidneys, was suspended
at a global level.
The entire process of organ transplantation was nascent,
as were the structure of Intensive Care Units and the
techniques used for preserving organs outside the body.
Elucidating the relevant immunological concepts was even
more critical for the success of the transplants because little
was known about rejection and there were few drugs capable
of preventing it.
With the discovery of a new immunosuppressant (cyclos-
porine) in the 1970s, the development of an effective preser-
vation solution and the standardization of organ removal,
transplantation procedures obtained encouraging results
starting in the 1980s (1).
Our country has pioneered numerous advancements in
this field. Just a few examples of the innovative Brazilian
spirit are Professor Euryclides de Jesus Zerbini, who
performed the first heart transplant in Latin America (and
the sixth in the world) in 1968; Prof. Silvano Raia, who
performed the first liver transplant in the world; and Prof.
José Medina who coordinates the world’s largest kidney
transplant program.
Currently, Brazil ranks second among all countries with
regard to the number of transplants performed and has the
highest level of public funding for this procedure; 95% of
transplants in the country are funded by the SUS (public
health care system).
Over the past seven years, the effective donor rate has
grown 69%, going from 9.9 donors per million population
(pmp) to 16.7 donors pmp; the reporting rate of potential
donors has increased 41%, and donation effectiveness has
risen by 21%.
In 2017, 5,929 kidney transplants (28.8 pmp) were per-
formed, which was 41.1% of the 14,425 transplants needed
(70 pmp). The number of transplants with cadaver donors
has been increasing and the number of living donors has
decreased, probably due to caution regarding the risk of late
donor complications.
Liver transplants have increased by 12% to 2,109 trans-
plants (10.2 pmp), which account for only 40.9% of the
6,182 transplants required (30 pmp), and São Paulo was
the state that performed the largest number of pro-
cedures in 2017.
In 2017, 380 heart transplants were performed (1.8 pmp),
which was 23% of the 1,649 transplants needed (8 pmp); it is
important to note that the agency’s utilization rate has
increased by 11%, but much remains to be done to reach the
established target of 40%.
Lung transplants were performed in only 4 states in 2017,
with a total of 112 procedures (0.5 pmp), accounting for only
6.7% of the 1649 transplants required (2 pmp); the 3.2%
utilization rate is still far below the required 20%. One of the
main reasons for this low utilization rate is the small number
of working teams (2).
For the transplant system to advance, it is vital that the
following components of the donation process improve:
legislation, funding, organization and education. Necessary
legal measures include implementing a voluntary donor
registration system and gaining greater control over trans-
plantation among nonfamily donors.
Regarding the financial measures, it has been 11 years
since the compensation for the hospitals and transplantation
teams was readjusted. Other procedures, such as posttrans-
plant follow-up, have received the same reimbursement for
20 years.
We need a supportive overview from the National Private
Healthcare System Agency (Agência Nacional da Saúde
Suplementar – ANS) and private healthcare companies
to give patients the support for transplantation coverage,
if needed. This improvement in funding is critical to
ensure the sustainability of the system.
Together with the support of the press, we must deepen
the population’s knowledge of the transplant system to
continue to encourage organ donation. Organ capture
logistics also pose challenges that need to be addressed,DOI: 10.6061/clinics/2019/e832
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given the vast size of our country. Coverage requires the
use of several types of transportation for safe and fast
pickups in increasingly distant locations. The motivation
of medical teams working in critical units for the diagnosis
of brain death and adequate maintenance of potential
donors is essential.
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